EDGAR Filing Documents for 0001047469-13-007768

Form 424B4 - Prospectus [Rule 424(b)(4)]:

SEC Accession No. 0001047469-13-007768

Filing Date

2013-07-25

Accepted

2013-07-25 11:12:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B4	a2216082z424b4.htm	424B4	2302704
2	G752160.JPG	g752160.jpg	GRAPHIC	19361
3	G779893.JPG	g779893.jpg	GRAPHIC	75347
4	G790631.JPG	g790631.jpg	GRAPHIC	18767
5	G1006277.JPG	g1006277.jpg	GRAPHIC	112386
6	G300003.JPG	g300003.jpg	GRAPHIC	58393
7	G367966.JPG	g367966.jpg	GRAPHIC	18615
8	G435591.JPG	g435591.jpg	GRAPHIC	15895
	Complete submission text file	0001047469-13-007768.txt		2743998

Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940

Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681

Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B4 | Act: 33 | File No.: 333-189358 | Film No.: 13985400
SIC: 2834 Pharmaceutical Preparations